Cessation of nucleos(t)ide analogues for patients with chronic hepatitis B in Taiwan: Risky but inevitable

J Chin Med Assoc. 2020 Jun;83(6):515-516. doi: 10.1097/JCMA.0000000000000317.

Authors

I-Cheng Lee^{1

2}, Yi-Hsiang Huang^{1

2

3}

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
² Faculty of Medicine, National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC.
³ Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.

PMID: 32243272
DOI: 10.1097/JCMA.0000000000000317

No abstract available

Publication types

Editorial
Comment

MeSH terms

Hepatitis B Surface Antigens
Hepatitis B e Antigens
Hepatitis B, Chronic* / drug therapy
Humans
Taiwan

Substances

Hepatitis B Surface Antigens
Hepatitis B e Antigens